INS and metabolic dysfunction-associated steatotic liver disease: The fact that changes in expression of a single gene have strong downstream effects leading to changes in liver metabolism, insulin sensitivity, and development of NAFLD and T2D, opens up the possibility for pharmacological manipulation.